• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

7-Bromo-5-(trifluoromethoxy)-1H-indazole: A Versatile Building Block for Pharmaceutical and Material Science Applications

The 1H-Indazole, 7-bromo-5-(trifluoromethoxy)- (CAS 2676196-05-5) represents an important heterocyclic compound with growing significance in modern chemical research. This brominated indazole derivative features a unique combination of trifluoromethoxy group and bromo substituent, making it particularly valuable for drug discovery and material innovation. The molecular structure of this compound offers multiple sites for further functionalization, enabling researchers to develop novel compounds with tailored properties.

Recent trends in pharmaceutical chemistry have shown increased interest in fluorinated indazole derivatives due to their enhanced metabolic stability and membrane permeability. The presence of both 7-bromo substitution and 5-trifluoromethoxy group in this compound makes it especially attractive for medicinal chemistry applications. Scientists frequently search for "7-bromo-5-trifluoromethoxy indazole synthesis" and "CAS 2676196-05-5 applications", reflecting the growing demand for this specialized chemical building block.

The physicochemical properties of 7-bromo-5-(trifluoromethoxy)-1H-indazole contribute to its versatility. The compound typically appears as a white to off-white crystalline powder with good stability under standard storage conditions. Its molecular weight of 281.02 g/mol and moderate polarity make it suitable for various synthetic transformations. Researchers particularly value the electron-withdrawing nature of both the bromo and trifluoromethoxy groups, which significantly influences the compound's reactivity in subsequent chemical reactions.

In pharmaceutical research, this indazole derivative serves as a key intermediate for developing potential therapeutic agents. The scaffold has shown promise in the design of kinase inhibitors, with particular relevance to "cancer research compounds" and "neurodegenerative disease treatments" - two of the most searched topics in medical chemistry today. The 7-bromo-5-(trifluoromethoxy)-1H-indazole structure allows for precise modifications that can enhance binding affinity to biological targets while maintaining favorable drug-like properties.

The synthetic utility of CAS 2676196-05-5 extends beyond pharmaceuticals into materials science. The trifluoromethoxy group contributes to increased thermal stability and altered electronic properties, making derivatives of this compound interesting candidates for organic electronic applications. Current research trends exploring "fluorinated materials for OLEDs" and "high-performance organic semiconductors" have identified similar indazole derivatives as promising components.

Quality control aspects of 7-bromo-5-(trifluoromethoxy)-1H-indazole are crucial for research applications. Reputable suppliers typically provide the compound with purity levels exceeding 97%, verified by HPLC analysis. Proper characterization includes 1H NMR, 13C NMR, and mass spectrometry data, ensuring researchers receive material suitable for sensitive synthetic applications. Storage recommendations generally suggest keeping the compound at 2-8°C in a dry environment to maintain stability over extended periods.

From a commercial perspective, the demand for specialty indazole derivatives like 7-bromo-5-(trifluoromethoxy)-1H-indazole has been steadily increasing. Market analysis reveals growing interest from both academic institutions and pharmaceutical companies, particularly those focused on "targeted drug discovery" and "fragment-based lead development". The compound's CAS number (2676196-05-5) has seen a noticeable increase in patent citations over recent years, indicating its rising importance in intellectual property related to medicinal chemistry.

Environmental and safety considerations for handling 7-bromo-5-(trifluoromethoxy)-1H-indazole follow standard laboratory protocols for organic compounds. While not classified as highly hazardous, proper personal protective equipment including gloves and safety glasses is recommended during handling. The compound should be used in well-ventilated areas, following good laboratory practices that align with current "green chemistry principles" - another trending topic in chemical research communities.

The future outlook for 7-bromo-5-(trifluoromethoxy)-1H-indazole appears promising, with potential applications expanding into new areas of research. As the pharmaceutical industry continues to explore "privileged scaffolds" for drug development, this indazole derivative offers valuable structural features that can be optimized for specific biological targets. Similarly, advances in material science may uncover novel applications for this and related compounds in electronic devices and specialty materials.

For researchers considering CAS 2676196-05-5 for their projects, several synthetic routes exist to incorporate this building block into more complex molecules. The bromo substituent readily participates in cross-coupling reactions, while the trifluoromethoxy group remains stable under most conditions, serving as a valuable structural element in the final products. These characteristics make 7-bromo-5-(trifluoromethoxy)-1H-indazole a versatile intermediate for both medicinal chemistry and materials science applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)